| 摘要 |
Use of the reduced form of nicotinamide adenine dinucleotide (NADH), the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), or a physiologically compatible salt thereof for the treatment of Alzheimer's disease is disclosed. Also disclosed is a composition for the treatment of Alzheimer's disease. The composition comprises NADH, NADPH or a physiologically compatible salt thereof and a pharmaceutically acceptable carrier.
|
